Cargando…

Recommendations for Probiotic Use in Humans—A 2014 Update

Probiotics have gained worldwide use during the last two decades. However, which probiotic to use in which clinical condition has remained confusing in some clinical conditions. We convened a workshop at Yale in conjunction with Harvard in 2005, inviting a spectrum of probiotic authorities to discus...

Descripción completa

Detalles Bibliográficos
Autor principal: Floch, Martin H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210857/
https://www.ncbi.nlm.nih.gov/pubmed/25310351
http://dx.doi.org/10.3390/ph7100999
_version_ 1782341459671777280
author Floch, Martin H.
author_facet Floch, Martin H.
author_sort Floch, Martin H.
collection PubMed
description Probiotics have gained worldwide use during the last two decades. However, which probiotic to use in which clinical condition has remained confusing in some clinical conditions. We convened a workshop at Yale in conjunction with Harvard in 2005, inviting a spectrum of probiotic authorities to discuss and reach conclusions on recommendations for use in common clinical conditions; the workshop was reconvened again in 2008 and in 2011. Each time the group of authorities was enlarged and varied depending on research studies. This article lists the recommendations updated from 2011 and is amended to bring it up to date in childhood and adult diarrhea, antibiotic-associated diarrhea, necrotizing enterocolitis, inflammatory bowel disorders, irritable bowel syndrome, allergic disorders, and radiation enteritis pending our 4th Triennial Yale/Harvard workshop to be convened in 2015.
format Online
Article
Text
id pubmed-4210857
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-42108572014-10-28 Recommendations for Probiotic Use in Humans—A 2014 Update Floch, Martin H. Pharmaceuticals (Basel) Review Probiotics have gained worldwide use during the last two decades. However, which probiotic to use in which clinical condition has remained confusing in some clinical conditions. We convened a workshop at Yale in conjunction with Harvard in 2005, inviting a spectrum of probiotic authorities to discuss and reach conclusions on recommendations for use in common clinical conditions; the workshop was reconvened again in 2008 and in 2011. Each time the group of authorities was enlarged and varied depending on research studies. This article lists the recommendations updated from 2011 and is amended to bring it up to date in childhood and adult diarrhea, antibiotic-associated diarrhea, necrotizing enterocolitis, inflammatory bowel disorders, irritable bowel syndrome, allergic disorders, and radiation enteritis pending our 4th Triennial Yale/Harvard workshop to be convened in 2015. MDPI 2014-10-10 /pmc/articles/PMC4210857/ /pubmed/25310351 http://dx.doi.org/10.3390/ph7100999 Text en © 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Floch, Martin H.
Recommendations for Probiotic Use in Humans—A 2014 Update
title Recommendations for Probiotic Use in Humans—A 2014 Update
title_full Recommendations for Probiotic Use in Humans—A 2014 Update
title_fullStr Recommendations for Probiotic Use in Humans—A 2014 Update
title_full_unstemmed Recommendations for Probiotic Use in Humans—A 2014 Update
title_short Recommendations for Probiotic Use in Humans—A 2014 Update
title_sort recommendations for probiotic use in humans—a 2014 update
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210857/
https://www.ncbi.nlm.nih.gov/pubmed/25310351
http://dx.doi.org/10.3390/ph7100999
work_keys_str_mv AT flochmartinh recommendationsforprobioticuseinhumansa2014update